ANDREA TRADER: Open Payments
NPI 1942239736 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 26 payments from 10 companies in 2025. Trend: 2023 $519 · 2024 $263 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $180 |
| AstraZeneca Pharmaceuticals LP | 3 | $159 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| GENZYME CORPORATION | 3 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| JAZZ PHARMACEUTICALS INC. | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $19 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, TEZSPIRE, XOLAIR, Sunosi, XYWAV, NEFFY.
Industry payments across SC — which companies pay providers there.
